Overview

A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
To evaluate drug-drug interaction between fimasartan and hydrochlorothiazide.
Phase:
Phase 1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd
Treatments:
Hydrochlorothiazide